The man who led Gilead’s au­toim­mune piv­ot heads to Boston; No­var­tis gets a new chief for its AI In­no­va­tion Cen­ter

The hos­pi­tal’s gone now but across the street from it, there used to be a clin­ic, a beat-up thing with peel­ing paint that, in a past life, a past city, had been a bank. John Sundy was a med­ical stu­dent train­ing at the hos­pi­tal, in down­town Philadel­phia. He walked in and saw a crowd of pa­tients in all man­ner of au­toim­mune con­di­tions wait­ing to see a tan, dis­tin­guished-look­ing man in a white lab coat: well-known rheuma­tol­o­gist Ralph De­Ho­r­atius.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA